Showing results (331-340 of 586) with videos related to

Sort By:
Pageof 59
American Heart Journal|November 4, 2004
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudyAlejandro Barbagelata, Robert M Califf, Elena B Sgarbossa, et al.
European Heart Journal|July 1, 2005
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromesStefano Savonitto, Mauricio G Cohen, Alessandro Politi, et al.
European Heart Journal|April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.
European Heart Journal|November 10, 2006
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromesCynthia M Westerhout, Adrián V Hernández, Ewout W Steyerberg, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
BMJ Open|August 16, 2015
Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR studyDavid Preiss, Laine E Thomas, Daniel M Wojdyla, et al.
American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.
The American Journal of Cardiology|September 17, 2002
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)Marino Labinaz, Mina Madan, J O'Conor O'Shea, et al.
Circulation|June 29, 2011
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trialRajendra H Mehta, T Bruce Ferguson, Renato D Lopes, et al.
Pageof 59